Skip to main content
OpenTrials
Completed

NCT Number: NCT03246711

Can Fasting Ramadan in the Third Trimester in Pregnancy Affects the Fetal Growth.

Prospective comparative cohort study including 159 pregnant women at the third trimester recruited from the antenatal clinic at EL-Demerdash outpatient clinic, and followed up during the holy month of Ramadan (from 18th June To 16th July 2015).

The patients recorded their pattern of fasting during Ramadan then grouped into three groups A, B, C regarding fasting state A- Non fasting group B- Partially fasting group C- Totally fasting group

.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Many pregnant muslims women fast during Ramadan Since fasting during Ramadan is one of the five pillars of Islam and is a central part of Muslim culture, many women may fear a loss of connection with their communities or would feel guilty if they did not observe Ramadan. Each year, about 400 million out of 1 billion Muslims do this duty. Such tasks like eating, drinking, and smoking are forbidden from sunrise until sunset. Fasting during pregnancy has been always considered as a debatable condition.

Many women ask their obstetricians if fasting is safe for their baby or not? There have been many studies on metabolic changes and different aspects of human health during and after Ramadan .but there have been few studies on the effect of fasting on pregnancy outcome and there are also some controversies in the findings of different studies.

All mothers within the age range of 20 - 35 years and in the 3rd trimester pregnancy (starting from 28 weeks) which is going to be calculated according to the date of the last menstrual period & confirmed ultrasonically, normal healthy women with average body mass index (BMI) and Women included have no medical disorder.

Women who fulfilled the eligibility criteria were subjected an ultrasound fetal biometry every 2 weeks till delivery and assess fetal weight after delivery.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age from 20 - 35 years.
  • Third trimester pregnancy (starting from 28 weeks) which is going to be calculated according to the date of the last menstrual period & confirmed by ultrasonography.
  • Normal healthy women with average body mass index (BMI). Normal range (18.5 to 25).
  • Women included have no medical disorder.

Exclusion criteria

  • History of systemic disorder.
  • Smoking narcotics or alcohol use.
  • Have previous history of fetal loss.
  • Multiple pregnancies.

Treatment and study plan

Fasting

Behavioral

Totally or partially fasting the holy month of ramadan for muslims

Primary outcomes

  1. Fetal growth

    Time frame: through study completion ( from 28 weeks pregnancy till delivery)

    assessment of the fetal growth biometry ( estimated fetal weight) every two weeks,

Secondary outcomes

  1. neonatal weight

    Time frame: at the time of delivery of each participant

    measured in grams after delivery

  2. mode of delivery

    Time frame: at the time of delivery of each participant

    percentages of emergency CS due to presumed fetal compromise

Sponsors and collaborators

Lead sponsor

Ain Shams Maternity Hospital

Other

Registry information

Official study title

The Effect of 3rd Trimester Ramdan Fasting on Obestetric Outcome

Important dates

Study start
2015
Primary completion
2015
Study completion
2016
First posted
Aug 11, 2017
Registry last updated
Aug 11, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.